RS20070185A - Use of androgens to reduce the likelihood of acquiring or to treat skin aging - Google Patents

Use of androgens to reduce the likelihood of acquiring or to treat skin aging

Info

Publication number
RS20070185A
RS20070185A RSP-2007/0185A RSP20070185A RS20070185A RS 20070185 A RS20070185 A RS 20070185A RS P20070185 A RSP20070185 A RS P20070185A RS 20070185 A RS20070185 A RS 20070185A
Authority
RS
Serbia
Prior art keywords
likelihood
loss
acquiring
androgens
reduce
Prior art date
Application number
RSP-2007/0185A
Other languages
English (en)
Inventor
Mohamed El-Alfy
Fernand Labrie
Lamia Azzi
Original Assignee
Endorecherche Inc.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endorecherche Inc., filed Critical Endorecherche Inc.,
Publication of RS20070185A publication Critical patent/RS20070185A/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

Novi postupci tretmana ili umanjenja verovatnoće nastanka bolesti kože koje su rezultat deficijencije androgena povezane sa starošću, posebno atrofije kože, gubitka kolagena, gubitka elastičnih vlakana, gubitka vezivnog tkiva, ce1ulita i nastanka bora, kod podložnih toplokrvnih životinja uključujući ljude, a koji podrazumevaju primenu androgena i/ili prekursora polnog steroida. Takođe su navedeni farmaceutski sastavi za dopremanje aktivnog (ih) sastoj (a) ka koji su korisni prema predmetnom pronalasku.
RSP-2007/0185A 2004-11-01 2005-10-31 Use of androgens to reduce the likelihood of acquiring or to treat skin aging RS20070185A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62411204P 2004-11-01 2004-11-01
PCT/CA2005/001652 WO2006047859A1 (en) 2004-11-01 2005-10-31 Use of androgens to reduce the likelihood of acquiring or to treat skin aging

Publications (1)

Publication Number Publication Date
RS20070185A true RS20070185A (en) 2008-09-29

Family

ID=36318842

Family Applications (1)

Application Number Title Priority Date Filing Date
RSP-2007/0185A RS20070185A (en) 2004-11-01 2005-10-31 Use of androgens to reduce the likelihood of acquiring or to treat skin aging

Country Status (20)

Country Link
US (1) US20060178352A1 (sr)
EP (1) EP1807062A4 (sr)
JP (1) JP2008517952A (sr)
KR (1) KR20070073964A (sr)
CN (1) CN101094676A (sr)
AP (1) AP2007003982A0 (sr)
AU (1) AU2005301035A1 (sr)
BR (1) BRPI0517950A (sr)
CA (1) CA2585666A1 (sr)
EA (1) EA200700983A1 (sr)
GE (1) GEP20094833B (sr)
HR (1) HRP20070183A2 (sr)
IL (1) IL182844A0 (sr)
MA (1) MA29220B1 (sr)
MX (1) MX2007005098A (sr)
NO (1) NO20072642L (sr)
RS (1) RS20070185A (sr)
TN (1) TNSN07163A1 (sr)
WO (1) WO2006047859A1 (sr)
ZA (1) ZA200703531B (sr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2749235C (en) 2004-10-20 2014-08-12 Endorecherche, Inc. Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cgmp phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women
CN101461294B (zh) 2006-06-01 2011-05-18 松下电器产业株式会社 洗衣机用无刷电动机以及搭载其的洗衣机
US8268806B2 (en) 2007-08-10 2012-09-18 Endorecherche, Inc. Pharmaceutical compositions
DE112014004733A5 (de) * 2013-10-15 2016-07-14 Chelac Holding Gmbh Steroid-Carbonsäureester, Zusammensetzungen, enthaltend Steroid-Carbonsäureester und Verwendung dieser bei lokal topischer Applikation für kosmetische oder dermatologische Zwecke
WO2017057743A1 (ja) * 2015-09-30 2017-04-06 富士フイルム株式会社 経皮吸収用組成物
JP2022548314A (ja) * 2019-09-23 2022-11-17 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 妊娠を遷延させるためおよび月経または妊娠の合併症の処置の方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL88180C (sr) * 1953-08-26
SK286051B6 (sk) * 1993-01-19 2008-02-05 Endorecherche Inc. Použitie prekurzora pohlavného steroidu na prípravu liečiva na prevenciu alebo liečenie znížených alebo nevyrovnaných koncentrácií pohlavných steroidov
FR2729854A1 (fr) * 1995-01-26 1996-08-02 Oreal Utilisation du sulfate de dehydroepi-androsterone dans une composition cosmetique ou dermatologique
US5736537A (en) * 1995-09-12 1998-04-07 Estee Lauder, Inc. Dehydroep:androsterone sailcylate useful against skin atrophy
US5709878A (en) * 1996-08-02 1998-01-20 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
US5869090A (en) * 1998-01-20 1999-02-09 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
AR018660A1 (es) * 1998-06-11 2001-11-28 Endorech Inc Una composicion farmaceutica que comprende androst-5-en-3beta,17beta-diol o una prodroga del mismo; un kit y metodos terapeuticos que utilizan dicha composicion y un parche transdermico.
US6117446A (en) * 1999-01-26 2000-09-12 Place; Virgil A. Drug dosage unit for buccal administration of steroidal active agents
FR2803750B1 (fr) * 2000-01-17 2004-04-02 Assist Publ Hopitaux De Paris Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs biologiques et de ses derives metaboliques comme anti-atrophiant
US20040198706A1 (en) * 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
US20030027804A1 (en) * 2001-06-27 2003-02-06 Van Der Hoop Roland Gerritsen Therapeutic combinations for the treatment of hormone deficiencies
JP2004002321A (ja) * 2002-03-11 2004-01-08 Takeda Chem Ind Ltd 性ホルモン依存性疾患治療剤
IL157535A0 (en) * 2003-08-21 2004-03-28 Topimed Ltd Preparations for the prevention of skin atrophy

Also Published As

Publication number Publication date
JP2008517952A (ja) 2008-05-29
TNSN07163A1 (en) 2008-11-21
GEP20094833B (en) 2009-11-25
EA200700983A1 (ru) 2008-04-28
EP1807062A4 (en) 2009-06-03
AU2005301035A1 (en) 2006-05-11
AP2007003982A0 (en) 2007-06-30
CN101094676A (zh) 2007-12-26
KR20070073964A (ko) 2007-07-10
HRP20070183A2 (en) 2007-08-31
NO20072642L (no) 2007-07-30
BRPI0517950A (pt) 2008-10-21
EP1807062A1 (en) 2007-07-18
US20060178352A1 (en) 2006-08-10
MX2007005098A (es) 2008-01-16
WO2006047859A1 (en) 2006-05-11
IL182844A0 (en) 2007-09-20
MA29220B1 (fr) 2008-02-01
CA2585666A1 (en) 2006-05-11
ZA200703531B (en) 2008-07-30

Similar Documents

Publication Publication Date Title
WO2006073786A3 (en) Ophthalmic compositions comprising steroid and cyclosporine for dry eye therapy
MX2007009368A (es) Metodo para estimular la sintesis de colagena y/o expresion de factor de crecimiento de queratinocitos.
TNSN07163A1 (en) Use of androgens to reduce the likelihood of acquiring or to treat skin aging
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
WO2005105107A3 (en) Hormone treatment of multiple sclerosis
MX2011008616A (es) Peptidos utiles en el tratamiento y/o cuidado de la piel , mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
WO2010036947A3 (en) Lipid based pharmaceutical preparations for oral and topical application; their compositions, methods, and uses thereof
TW201129368A (en) Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions
TW200602030A (en) Use of loteprednol etabonate for the treatment of dry eye
MX338512B (es) Dispositivo para tratamiento médico y/o cosmético.
PT2210588E (pt) Composição expansível, essencialmente isenta de ingredientes farmaceuticamente activos para o tratamento da pele humana
HK1098960A1 (en) Method and composition for treating rhinitis
IL174525A0 (en) Medicamentously targeted local lipolysis
WO2006086693A3 (en) Medical devices
HK1112721A1 (en) Tissue disruption treatment and composition for use thereof
NO20055390L (no) Thorium-227 for anvendelse i radioterapi pa mykvevssykdommer
RS20070399A (en) Device for the hot-dip coating of a metal strip
ATE422892T1 (de) Verwendung von hyaluronsäure zur herstellung von zusammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle
DE60330888D1 (de) Verwendung von drospirenon zur behandlung von hypertension
TW200511999A (en) Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and parathyroid hormone
WO2009106715A3 (fr) Peptide derive d'une proteine de la famille des aquaporines
NO20071238L (no) Fremgangsmater for leging av skader ved human IL-18 administrering
HK1111924A1 (en) Depigmenting or brightening cosmetic composition comprising at least one oxazolin as an active ingredient
NO20060655L (no) 2-alkyliden-19-Nor-vitamin D derivater for behandling av osteofeni eller osteoporose hos hannkjonn
WO2003032909A3 (en) Methods of treating skin with diphosphonate derivatives